33 related articles for article (PubMed ID: 38627241)
1. Time to diagnosis among young patients with cancer.
Winestone LE; Wilkes JJ; Puccetti D; Keegan THM; Henk HJ; McPheeters J; Kahn JM; Ginsberg J; Wong S; Timberline S; Malogolowkin M; Pollock BH; Alvarez E
Pediatr Blood Cancer; 2024 Jun; ():e30997. PubMed ID: 38864147
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
Foxworthy B; Dai C; Davis EC; Xavier AC; Brackett J; Dickens D; Kahn A; Martinez I; Sharma A; Schwalm C; Foley J; Wilkes J; ; Bhatia S; Levine JM; Johnston EE; Wolfson JA
Pediatr Blood Cancer; 2024 May; ():e31082. PubMed ID: 38804869
[TBL] [Abstract][Full Text] [Related]
3. Cancer Profiles, Times to Treatment, and Survival for Adolescents and Young Adults: Comparisons with Children and Older Adults in New South Wales, Australia.
Li M; Anazodo A; Dallapozza L; Baeza PK; Roder D; Currow D
J Adolesc Young Adult Oncol; 2022 Oct; 11(5):443-450. PubMed ID: 34714131
[No Abstract] [Full Text] [Related]
4. A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
Liu L; Moke DJ; Tsai KY; Hwang A; Freyer DR; Hamilton AS; Zhang J; Cockburn M; Deapen D
J Natl Cancer Inst; 2019 May; 111(5):509-518. PubMed ID: 30321398
[TBL] [Abstract][Full Text] [Related]
5. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
Roth ME; O'Mara AM; Seibel NL; Dickens DS; Langevin AM; Pollock BH; Freyer DR
J Oncol Pract; 2016 Apr; 12(4):e388-95. PubMed ID: 27026648
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial Needs and Preferences for Care among Adolescent and Young Adult Cancer Patients (Ages 15-39): A Qualitative Study.
Avutu V; Lynch KA; Barnett ME; Vera JA; Glade Bender JL; Tap WD; Atkinson TM
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158975
[TBL] [Abstract][Full Text] [Related]
7. Adolescents and young adults (AYA) with cancer: the clinical course of COVID-19 infections.
Wolfson JA; Davis ES; Saha A; Martinez I; McCall D; Kothari P; Brackett J; Dickens DS; Kahn AR; Schwalm C; Sharma A; Richman J; Cuglievan B; ; Bhatia S; Dai C; Levine JM; Johnston EE
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38627241
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials.
Wayant C; Fitzgerald K; Hemmerich C; Geng Y; Freyer D; Roth M
JCO Oncol Pract; 2023 Nov; 19(11):1048-1052. PubMed ID: 37748116
[TBL] [Abstract][Full Text] [Related]
9. Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer.
Wolfson JA; Kenzik KM; Foxworthy B; Salsman JM; Donahue K; Nelson M; Littrell MB; Williams GR; Levine JM
J Natl Compr Canc Netw; 2023 Aug; 21(8):881-888. PubMed ID: 37549915
[TBL] [Abstract][Full Text] [Related]
10. AYA Considerations for Aggressive Lymphomas.
Llaurador G; Giulino-Roth L
Curr Hematol Malig Rep; 2021 Feb; 16(1):61-71. PubMed ID: 33728589
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
